Form 4: Applied Therapeutics Officer Sells Shares to Cover Tax Obligations

Constantine Chinoporos, an officer at Applied Therapeutics, sold 447 shares of common stock on March 4, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On March 4, 2025, Constantine Chinoporos, Chief Operating Officer and Chief Business Officer of Applied Therapeutics, Inc. (APLT), sold 447 shares of common stock at a price of $0.44 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting and settlement of compensatory Restricted Stock Units (RSUs).
• Following the transaction, Chinoporos directly owns 271,436 shares of Applied Therapeutics common stock.
• A Power of Attorney document was also filed, granting Les Funtleyder, Catherine Thorpe, Michael Schwartz, Jackson Nye, Julie Li, and Dolores Muiz the authority to act on behalf of Constantine Chinoporos for SEC filings related to Applied Therapeutics.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to an officer's stock sale to cover tax obligations, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are standard practice for company insiders and officers when they trade their company's stock. These filings provide transparency to the market regarding insider transactions.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the small number of shares involved.

Key Dates